| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,147 |
5,982 |
$1.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,226 |
5,292 |
$506K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,701 |
2,098 |
$325K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,657 |
947 |
$246K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,033 |
462 |
$198K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
226 |
205 |
$193K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,478 |
1,378 |
$179K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,263 |
1,515 |
$176K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,501 |
1,268 |
$147K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,273 |
999 |
$130K |
| 80053 |
Comprehensive metabolic panel |
8,502 |
5,908 |
$129K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,695 |
1,321 |
$117K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
297 |
243 |
$108K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,556 |
2,327 |
$93K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,044 |
986 |
$89K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,809 |
1,379 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,985 |
7,368 |
$52K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,057 |
2,638 |
$43K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
140 |
135 |
$43K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,015 |
1,437 |
$36K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,021 |
1,645 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,786 |
1,103 |
$28K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
242 |
209 |
$27K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
74 |
37 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
695 |
520 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,319 |
1,062 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
392 |
382 |
$20K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
30 |
27 |
$20K |
| 97162 |
|
256 |
222 |
$20K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,077 |
1,005 |
$19K |
| 80320 |
|
512 |
299 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
181 |
177 |
$17K |
| 86803 |
|
638 |
500 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
205 |
140 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,554 |
1,421 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
68 |
52 |
$13K |
| 80061 |
Lipid panel |
758 |
669 |
$13K |
| 84484 |
|
544 |
328 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
270 |
269 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
268 |
246 |
$11K |
| 87653 |
|
302 |
195 |
$11K |
| 86140 |
|
880 |
647 |
$10K |
| J3490 |
Unclassified drugs |
1,059 |
636 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
48 |
25 |
$8K |
| A9270 |
Non-covered item or service |
11,417 |
5,431 |
$8K |
| 96367 |
|
49 |
29 |
$8K |
| 83721 |
|
353 |
310 |
$7K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,038 |
675 |
$6K |
| 64483 |
|
14 |
12 |
$6K |
| 81003 |
|
2,100 |
1,401 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
234 |
94 |
$5K |
| 83690 |
|
832 |
529 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
232 |
172 |
$5K |
| 94729 |
|
570 |
528 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
97 |
95 |
$5K |
| 83605 |
|
165 |
83 |
$5K |
| 94010 |
|
306 |
288 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
66 |
65 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
14 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
68 |
42 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
97 |
95 |
$4K |
| 86850 |
|
558 |
363 |
$4K |
| 80055 |
|
121 |
69 |
$4K |
| 80306 |
|
457 |
284 |
$3K |
| 99233 |
Prolong inpt eval add15 m |
84 |
50 |
$3K |
| 85379 |
|
146 |
143 |
$3K |
| 80081 |
|
69 |
68 |
$3K |
| 82728 |
|
139 |
134 |
$3K |
| 85014 |
|
489 |
336 |
$3K |
| 83735 |
|
375 |
173 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
74 |
37 |
$3K |
| 87581 |
|
74 |
37 |
$2K |
| 87486 |
|
74 |
37 |
$2K |
| 93296 |
|
172 |
130 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
73 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
14 |
14 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
55 |
42 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
126 |
98 |
$2K |
| 85018 |
|
482 |
335 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
12 |
$2K |
| 85610 |
|
675 |
472 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
48 |
24 |
$2K |
| 87070 |
|
41 |
41 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,097 |
705 |
$2K |
| 86701 |
|
153 |
76 |
$2K |
| 82950 |
|
261 |
178 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,263 |
1,382 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
13 |
13 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
844 |
793 |
$1K |
| 84145 |
|
51 |
26 |
$1K |
| 90686 |
|
58 |
46 |
$864.81 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
111 |
109 |
$823.28 |
| J2704 |
Injection, propofol, 10 mg |
1,720 |
1,362 |
$714.73 |
| 80076 |
|
16 |
12 |
$711.57 |
| 84703 |
|
170 |
126 |
$652.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
831 |
509 |
$543.10 |
| 87186 |
|
54 |
41 |
$523.47 |
| 81025 |
|
125 |
107 |
$427.92 |
| 83550 |
|
39 |
37 |
$414.49 |
| 94726 |
|
13 |
13 |
$400.78 |
| 83540 |
|
39 |
37 |
$390.30 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
712 |
517 |
$389.91 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
66 |
65 |
$370.70 |
| 94060 |
|
12 |
12 |
$358.91 |
| 85652 |
|
68 |
66 |
$321.75 |
| 97161 |
|
13 |
12 |
$283.60 |
| 88738 |
|
44 |
37 |
$190.05 |
| 82948 |
|
34 |
12 |
$169.52 |
| 85730 |
|
77 |
62 |
$161.70 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
112 |
99 |
$144.04 |
| 73630 |
|
15 |
14 |
$106.12 |
| 87340 |
|
12 |
12 |
$98.38 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
40 |
39 |
$92.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,055 |
717 |
$60.52 |
| 81000 |
|
17 |
13 |
$28.63 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
105 |
53 |
$18.89 |
| 36415 |
Collection of venous blood by venipuncture |
57 |
39 |
$18.24 |
| 83615 |
|
16 |
15 |
$12.36 |
| J2060 |
Injection, lorazepam, 2 mg |
38 |
14 |
$7.98 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
58 |
24 |
$5.63 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
25 |
12 |
$1.28 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
75 |
56 |
$0.00 |